13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q2 2024 · Filed July 10, 2024 · Accession 0000950123-24-006464
Total Value
$91.4M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Centessa Pharmaceuticals plc | CNTA | 3,931,818 | $35.5M | 38.83% |
| 2 | Kyverna Therapeutics, Inc. | KYTX | 4,523,924 | $33.9M | 37.11% |
| 3 | Dyne Therapeutics, Inc. | DYN | 407,499 | $14.4M | 15.73% |
| 4 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $4.2M | 4.58% |
| 5 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $3.4M | 3.75% |